Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.

We studied the efficacy of sulbactam, a beta-lactamase inhibitor, in combination with ceftriaxone in vitro and in experimental endocarditis due to an Escherichia coli strain producing an extended-spectrum beta-lactamase most similar to SHV-2, a new mechanism of resistance to broad-spectrum cephalosp...

詳細記述

保存先:

書誌詳細
出版年:	Antimicrob Agents Chemother
主要な著者:	Fantin, B, Pangon, B, Potel, G, Caron, F, Vallée, E, Vallois, J M, Mohler, J, Buré, A, Philippon, A, Carbon, C
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 1990
主題:	Research Article
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171647/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2188586/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.4.581
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.

類似資料